Catastrophic	O
expenditure	O
and	O
impoverishment	O
of	O
patients	O
affected	O
by	O
7	O
rare	B:C0678236
diseases	I:C0678236
in	O
China	O
China	O
is	O
actively	O
promoting	O
regulation	O
of	O
rare	O
diseases	I:C0678236
,	O
rare	O
disease	I:C0678236
and	O
orphan	O
drugs	I:C0013232
have	O
been	O
formally	O
incorporated	O
into	O
the	O
national	O
planning	O
.	O

Catastrophic	O
expenditure	O
and	O
impoverishment	O
of	O
patients	O
affected	O
by	O
7	O
rare	O
diseases	I:C0678236
in	O
China	B:C0008115
China	O
is	O
actively	O
promoting	O
regulation	O
of	O
rare	O
diseases	I:C0678236
,	O
rare	O
disease	I:C0678236
and	O
orphan	O
drugs	I:C0013232
have	O
been	O
formally	O
incorporated	O
into	O
the	O
national	O
planning	O
.	O

Catastrophic	O
expenditure	O
and	O
impoverishment	O
of	O
patients	O
affected	O
by	O
7	O
rare	O
diseases	I:C0678236
in	O
China	O
China	B:C0008115
is	O
actively	O
promoting	O
regulation	O
of	O
rare	O
diseases	I:C0678236
,	O
rare	O
disease	I:C0678236
and	O
orphan	O
drugs	I:C0013232
have	O
been	O
formally	O
incorporated	O
into	O
the	O
national	O
planning	O
.	O

Catastrophic	O
expenditure	O
and	O
impoverishment	O
of	O
patients	O
affected	O
by	O
7	O
rare	O
diseases	I:C0678236
in	O
China	O
China	O
is	O
actively	O
promoting	O
regulation	O
of	O
rare	B:C0678236
diseases	I:C0678236
,	O
rare	O
disease	I:C0678236
and	O
orphan	O
drugs	I:C0013232
have	O
been	O
formally	O
incorporated	O
into	O
the	O
national	O
planning	O
.	O

Catastrophic	O
expenditure	O
and	O
impoverishment	O
of	O
patients	O
affected	O
by	O
7	O
rare	O
diseases	I:C0678236
in	O
China	O
China	O
is	O
actively	O
promoting	O
regulation	O
of	O
rare	O
diseases	I:C0678236
,	O
rare	B:C0678236
disease	I:C0678236
and	O
orphan	O
drugs	I:C0013232
have	O
been	O
formally	O
incorporated	O
into	O
the	O
national	O
planning	O
.	O

Catastrophic	O
expenditure	O
and	O
impoverishment	O
of	O
patients	O
affected	O
by	O
7	O
rare	O
diseases	I:C0678236
in	O
China	O
China	O
is	O
actively	O
promoting	O
regulation	O
of	O
rare	O
diseases	I:C0678236
,	O
rare	O
disease	I:C0678236
and	O
orphan	B:C0013232
drugs	I:C0013232
have	O
been	O
formally	O
incorporated	O
into	O
the	O
national	O
planning	O
.	O

However	O
,	O
few	O
studies	B:C2603343
have	O
been	O
done	O
to	O
evaluate	O
the	O
affordability	O
of	O
rare	O
disease	I:C0678236
patients	O
in	O
China	O
.	O

However	O
,	O
few	O
studies	O
have	O
been	O
done	O
to	O
evaluate	O
the	O
affordability	O
of	O
rare	B:C0678236
disease	I:C0678236
patients	O
in	O
China	O
.	O

However	O
,	O
few	O
studies	O
have	O
been	O
done	O
to	O
evaluate	O
the	O
affordability	O
of	O
rare	O
disease	I:C0678236
patients	O
in	O
China	B:C0008115
.	O

This	O
study	O
aims	O
to	O
provide	O
policy	B:C0242456
recommendations	O
for	O
the	O
establishment	O
of	O
social	O
security	I:C0282574
mechanism	I:C0282574
for	O
rare	O
diseases	I:C0678236
in	O
China	O
,	O
so	O
as	O
to	O
address	O
the	O
problem	O
of	O
poverty	O
caused	O
by	O
these	O
diseases	O
.	O

This	O
study	O
aims	O
to	O
provide	O
policy	O
recommendations	O
for	O
the	O
establishment	O
of	O
social	B:C0282574
security	I:C0282574
mechanism	I:C0282574
for	O
rare	O
diseases	I:C0678236
in	O
China	O
,	O
so	O
as	O
to	O
address	O
the	O
problem	O
of	O
poverty	O
caused	O
by	O
these	O
diseases	O
.	O

This	O
study	O
aims	O
to	O
provide	O
policy	O
recommendations	O
for	O
the	O
establishment	O
of	O
social	O
security	I:C0282574
mechanism	I:C0282574
for	O
rare	B:C0678236
diseases	I:C0678236
in	O
China	O
,	O
so	O
as	O
to	O
address	O
the	O
problem	O
of	O
poverty	O
caused	O
by	O
these	O
diseases	O
.	O

This	O
study	O
aims	O
to	O
provide	O
policy	O
recommendations	O
for	O
the	O
establishment	O
of	O
social	O
security	I:C0282574
mechanism	I:C0282574
for	O
rare	O
diseases	I:C0678236
in	O
China	B:C0008115
,	O
so	O
as	O
to	O
address	O
the	O
problem	O
of	O
poverty	O
caused	O
by	O
these	O
diseases	O
.	O

This	O
study	O
aims	O
to	O
provide	O
policy	O
recommendations	O
for	O
the	O
establishment	O
of	O
social	O
security	I:C0282574
mechanism	I:C0282574
for	O
rare	O
diseases	I:C0678236
in	O
China	O
,	O
so	O
as	O
to	O
address	O
the	O
problem	O
of	O
poverty	O
caused	O
by	O
these	O
diseases	B:C0012634
.	O

A	O
total	O
of	O
7	O
rare	B:C0678236
diseases	I:C0678236
were	O
selected	O
by	O
Delphi	O
method	I:C0011216
.	O

A	O
total	O
of	O
7	O
rare	O
diseases	I:C0678236
were	O
selected	O
by	O
Delphi	B:C0011216
method	I:C0011216
.	O

Affordability	O
of	O
treatment	B:C0087111
for	O
the	O
7	O
rare	O
diseases	I:C0678236
was	O
assessed	O
through	O
annual	O
per	O
capital	O
income	O
,	O
catastrophic	O
expenditure	O
and	O
impoverishment	O
expenditure	O
among	O
urban	O
and	O
rural	O
residents	I:C1257890
in	O
China	O
.	O

Affordability	O
of	O
treatment	O
for	O
the	O
7	O
rare	B:C0678236
diseases	I:C0678236
was	O
assessed	O
through	O
annual	O
per	O
capital	O
income	O
,	O
catastrophic	O
expenditure	O
and	O
impoverishment	O
expenditure	O
among	O
urban	O
and	O
rural	O
residents	I:C1257890
in	O
China	O
.	O

Affordability	O
of	O
treatment	O
for	O
the	O
7	O
rare	O
diseases	I:C0678236
was	O
assessed	O
through	O
annual	O
per	O
capital	O
income	O
,	O
catastrophic	O
expenditure	O
and	O
impoverishment	O
expenditure	O
among	O
urban	B:C1257890
and	O
rural	O
residents	I:C1257890
in	O
China	O
.	O

Affordability	O
of	O
treatment	O
for	O
the	O
7	O
rare	O
diseases	I:C0678236
was	O
assessed	O
through	O
annual	O
per	O
capital	O
income	O
,	O
catastrophic	O
expenditure	O
and	O
impoverishment	O
expenditure	O
among	O
urban	O
and	O
rural	B:C1257890
residents	I:C1257890
in	O
China	O
.	O

Affordability	O
of	O
treatment	O
for	O
the	O
7	O
rare	O
diseases	I:C0678236
was	O
assessed	O
through	O
annual	O
per	O
capital	O
income	O
,	O
catastrophic	O
expenditure	O
and	O
impoverishment	O
expenditure	O
among	O
urban	O
and	O
rural	O
residents	I:C1257890
in	O
China	B:C0008115
.	O

Assessed	O
through	O
annual	O
per	O
capital	O
income	O
,	O
health	O
expenditure	O
for	O
the	O
7	O
rare	B:C0678236
diseases	I:C0678236
are	O
all	O
rather	O
high	O
.	O

The	O
highest	O
health	O
expenditure	O
is	O
equivalent	O
to	O
income	O
of	O
69.34	O
years	O
of	O
one	O
urban	B:C1257890
resident	I:C1257890
,	O
and	O
the	O
burden	O
is	O
heavier	O
for	O
rural	O
residents	I:C1257890
.	O

The	O
highest	O
health	O
expenditure	O
is	O
equivalent	O
to	O
income	O
of	O
69.34	O
years	O
of	O
one	O
urban	O
resident	I:C1257890
,	O
and	O
the	O
burden	O
is	O
heavier	O
for	O
rural	B:C1257890
residents	I:C1257890
.	O

Through	O
catastrophic	O
expenditure	O
assessment	O
,	O
proportions	O
of	O
the	O
population	B:C1257890
experiencing	O
catastrophic	O
expenditure	O
caused	O
by	O
the	O
7	O
rare	O
diseases	I:C0678236
are	O
all	O
under	O
0.167	O
‰.	O

Through	O
catastrophic	O
expenditure	O
assessment	O
,	O
proportions	O
of	O
the	O
population	O
experiencing	O
catastrophic	O
expenditure	O
caused	O
by	O
the	O
7	O
rare	B:C0678236
diseases	I:C0678236
are	O
all	O
under	O
0.167	O
‰.	O

However	O
,	O
once	O
one	O
is	O
ill	B:C0221423
and	O
taking	O
medications	O
,	O
he	O
will	O
suffer	O
from	O
catastrophic	O
health	O
expenditure	O
.	O

However	O
,	O
once	O
one	O
is	O
ill	O
and	O
taking	O
medications	B:C4284232
,	O
he	O
will	O
suffer	O
from	O
catastrophic	O
health	O
expenditure	O
.	O

Through	O
impoverishment	O
expenditure	O
assessment	O
,	O
the	O
proportions	O
of	O
impoverishment	O
payment	O
are	O
low	O
among	O
both	O
urban	B:C1257890
and	O
rural	O
residents	I:C1257890
,	O
but	O
the	O
7	O
rare	O
diseases	I:C0678236
could	O
lead	O
nearly	O
4.6	O
million	O
people	O
into	O
poverty	O
on	O
a	O
national	O
scale	O
.	O

Through	O
impoverishment	O
expenditure	O
assessment	O
,	O
the	O
proportions	O
of	O
impoverishment	O
payment	O
are	O
low	O
among	O
both	O
urban	O
and	O
rural	B:C1257890
residents	I:C1257890
,	O
but	O
the	O
7	O
rare	O
diseases	I:C0678236
could	O
lead	O
nearly	O
4.6	O
million	O
people	O
into	O
poverty	O
on	O
a	O
national	O
scale	O
.	O

Through	O
impoverishment	O
expenditure	O
assessment	O
,	O
the	O
proportions	O
of	O
impoverishment	O
payment	O
are	O
low	O
among	O
both	O
urban	O
and	O
rural	O
residents	I:C1257890
,	O
but	O
the	O
7	O
rare	B:C0678236
diseases	I:C0678236
could	O
lead	O
nearly	O
4.6	O
million	O
people	O
into	O
poverty	O
on	O
a	O
national	O
scale	O
.	O

Through	O
impoverishment	O
expenditure	O
assessment	O
,	O
the	O
proportions	O
of	O
impoverishment	O
payment	O
are	O
low	O
among	O
both	O
urban	O
and	O
rural	O
residents	I:C1257890
,	O
but	O
the	O
7	O
rare	O
diseases	I:C0678236
could	O
lead	O
nearly	O
4.6	O
million	O
people	B:C1257890
into	O
poverty	O
on	O
a	O
national	O
scale	O
.	O

The	O
affordability	O
of	O
treatment	B:C0087111
for	O
rare	O
disease	I:C0678236
as	O
well	O
as	O
orphan	O
drugs	I:C0013232
is	O
rather	O
poor	O
.	O

The	O
affordability	O
of	O
treatment	O
for	O
rare	B:C0678236
disease	I:C0678236
as	O
well	O
as	O
orphan	O
drugs	I:C0013232
is	O
rather	O
poor	O
.	O

The	O
affordability	O
of	O
treatment	O
for	O
rare	O
disease	I:C0678236
as	O
well	O
as	O
orphan	B:C0013232
drugs	I:C0013232
is	O
rather	O
poor	O
.	O

Residents	B:C2347958
of	O
different	O
income	O
levels	O
all	O
have	O
difficulties	O
to	O
afford	O
the	O
treatment	O
for	O
rare	O
diseases	I:C0678236
,	O
so	O
poverty	O
caused	O
by	O
rare	O
diseases	I:C0678236
is	O
quite	O
widespread	O
.	O

Residents	O
of	O
different	O
income	O
levels	O
all	O
have	O
difficulties	O
to	O
afford	O
the	O
treatment	B:C0087111
for	O
rare	O
diseases	I:C0678236
,	O
so	O
poverty	O
caused	O
by	O
rare	O
diseases	I:C0678236
is	O
quite	O
widespread	O
.	O

Residents	O
of	O
different	O
income	O
levels	O
all	O
have	O
difficulties	O
to	O
afford	O
the	O
treatment	O
for	O
rare	B:C0678236
diseases	I:C0678236
,	O
so	O
poverty	O
caused	O
by	O
rare	O
diseases	I:C0678236
is	O
quite	O
widespread	O
.	O

Residents	O
of	O
different	O
income	O
levels	O
all	O
have	O
difficulties	O
to	O
afford	O
the	O
treatment	O
for	O
rare	O
diseases	I:C0678236
,	O
so	O
poverty	O
caused	O
by	O
rare	B:C0678236
diseases	I:C0678236
is	O
quite	O
widespread	O
.	O

Residents	O
of	O
different	O
income	O
levels	O
all	O
have	O
difficulties	O
to	O
afford	O
the	O
treatment	O
for	O
rare	O
diseases	I:C0678236
,	O
so	O
poverty	O
caused	O
by	O
rare	O
diseases	I:C0678236
is	O
quite	O
widespread	B:C0205391
.	O

Therefore	O
,	O
social	B:C0282574
security	I:C0282574
mechanism	I:C0282574
for	O
rare	O
disease	I:C0678236
patients	O
should	O
be	O
established	O
and	O
specific	O
payment	O
pattern	O
for	O
orphan	O
drugs	I:C0013232
should	O
be	O
set	O
up	O
.	O

Therefore	O
,	O
social	O
security	I:C0282574
mechanism	I:C0282574
for	O
rare	B:C0678236
disease	I:C0678236
patients	O
should	O
be	O
established	O
and	O
specific	O
payment	O
pattern	O
for	O
orphan	O
drugs	I:C0013232
should	O
be	O
set	O
up	O
.	O

Therefore	O
,	O
social	O
security	I:C0282574
mechanism	I:C0282574
for	O
rare	O
disease	I:C0678236
patients	O
should	O
be	O
established	O
and	O
specific	O
payment	O
pattern	O
for	O
orphan	B:C0013232
drugs	I:C0013232
should	O
be	O
set	O
up	O
.	O

